1Hoppe B,Mohr M,Roots-Weiss A,et al.Improvement of tumor cell depletion by combining immunomagnetic positive selection of CD34-positive hematopoietic stem cells and negative selection(purging) of tumor cells.Bone Marrow Transplant,1999,23(8):809
2Porrata L F,Litzow M R,Markovic S N.Immune reconstitution after autologous hematopoietic stem cell transplantation.Mayo clinic Proceedings,2001,76(4):407
3Burns L J,Weisdorf D J,DeFor T E,et al.IL-2-based immunotherapy after autologous transplantation for lymphoma and breast cancer induces immune activation and cytokine release:a phase Ⅰ /Ⅱ trial.Bone Marrow Transplantation,2003,32(2):177
4Bonig H,Laws H J,Wundes A,et al.In vivo cytokine responses to interleukin-2 immunotherapy after autologous stem cell transplantation in children with solid tumors.Bone Marrow Transplant,2000,26(1):91
5Ahlberg R,MacNamara B,Andersson M,et al.Stimulation of T-cell cytokine production and NK-cell function by IL-2,IFN-alpha and histamine treatment during remission of non-Hodgkin's lymphoma.Hematol J,2003,4(5):336
6Narcdi P.Histamine as adjunct to immunotherapy.Semin Oncol,2002,29(1):31
7Koh C Y,Blazar B R,George T,et al.Augmentation of antitumor effects by Nk-cell inhibitory receptor blockade in vitro and in vivo.Blood,2001,97(10):3132
8Jacobsen E,Freedman A.B-cell purging in autologous stem-cell transplantation for non-Hodgkin lymphoma.Lancet Onco1,2004,5(12):711
9Belhadj K,Delfau-Larue M H,Elgnaoui T,et al.Efficiency of in vivo purging with rituximab prior to autologous peripheral blood progenitor cell transplantation in B-cell non-Hodgkin's lymphoma:a single institution study.Ann 0ncol,2004,15(3):504
10Kreuzer K A,Kluhs C,Baskaynak G,et al.Filgrastim-induced stem cell mobilization in chronic myeloid leukaemia patients during imatinib theraphy:safety,feasibility and evidence for an efficient in vivo purging.Br J Haematol,2004,124(2):195
